Peter Franks
Keine laufenden Positionen mehr
Profil
Peter D.
Franks worked as an Associate Director-Project Management at Questcor Pharmaceuticals, Inc. and as a Senior Director-Drug Development at Processa Pharmaceuticals, Inc. He completed his undergraduate degree at the University of Richmond and his graduate degree at John Hopkins University Atlantic Basin Policy Institute.
Ehemalige bekannte Positionen von Peter Franks
| Unternehmen | Position | Ende |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | General Counsel | 01.04.2024 |
| QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Ausbildung von Peter Franks
| University of Richmond | Undergraduate Degree |
| John Hopkins University Atlantic Basin Policy Institute | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
